Ioflupane API is a pharmaceutical-grade dopamine transporter (DaT) ligand used in the preparation of Ioflupane I-123 radiopharmaceuticals for Single Photon Emission Computed Tomography (SPECT) imaging. It enables visualization of dopamine transporter density in the brain and assists in evaluating disorders affecting the dopaminergic system.
Ioflupane-based imaging is primarily used to support the diagnosis of Parkinsonian syndromes, differentiate essential tremor from neurodegenerative parkinsonism, and assist in the evaluation of Dementia with Lewy Bodies (DLB) where clinically appropriate.
Manufactured under WHO-GMP-certified facilities, our Ioflupane API is produced using advanced pharmaceutical manufacturing processes to ensure exceptional purity, stability, and batch-to-batch consistency. Every batch undergoes comprehensive quality testing and is supplied with Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), Technical Data Sheet (TDS), and complete regulatory documentation.
Ioflupane API is used in the manufacture of Ioflupane I-123 radiopharmaceutical formulations for SPECT imaging of dopamine transporters in the brain.
Ioflupane selectively binds to dopamine transporters in the striatum, enabling visualization of dopaminergic neuron integrity during SPECT imaging after radiolabeling with iodine-123.
Yes. We provide CoA, MSDS, Technical Data Sheet (TDS), Product Specifications, and complete regulatory documentation with every shipment.
Yes. We supply Ioflupane API in commercial quantities for pharmaceutical and radiopharmaceutical manufacturers worldwide.
Get Bulk Quote via WhatsApp